Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | OPRL1 | P41146 | 8/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12716807 | 0.94 | CNR1 (0.36) | CNR2CNR1HTR2AOPRL1FFAR1 | |
| SCHEMBL10302109 | 0.90 | CNR2 (0.39) | CNR2CNR1OPRL1 | |
| SCHEMBL10302106 | 0.90 | FFAR1 (0.38) | OPRL1FFAR1MEN1POLBHTT | |
| SCHEMBL12735185 | 0.89 | HTR2A (0.39) | CNR2CNR1HTR2AL3MBTL1 | |
| SCHEMBL12739755 | 0.88 | MEN1 (0.37) | CNR2CNR1HTR2AFFAR1MEN1 | |
| SCHEMBL12716808 | 0.88 | OPRL1 (0.37) | OPRL1FFAR1MEN1POLBHTT | |
| SCHEMBL12889860 | 0.87 | CNR2 (0.42) | CNR2CNR1HTR2AFFAR1MEN1 | |
| SCHEMBL10303071 | 0.87 | OPRL1 (0.37) | OPRL1FFAR1MEN1POLBHTT | |
| SCHEMBL10302112 | 0.87 | FFAR1 (0.38) | OPRL1FFAR1MEN1POLBHTT | |
| SCHEMBL19722481 | 0.86 | OPRL1 (0.41) | HTR2AOPRL1FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110037024-A1 | THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110037024-A1 | THREE-RING LIQUID CRYSTAL COMPOUND HAVING LATERAL FLUORINE, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | LEF1, LAS1L, L3MBTL3 | CNR2 2145/4885CNR1 1338/4885HTR2A 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.